4//SEC Filing
LEWIS JOSEPH 4
Accession 0000899243-21-011086
CIK 0001576263other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 9:30 PM ET
Size
30.8 KB
Accession
0000899243-21-011086
Insider Transaction Report
Form 4
LEWIS JOSEPH
10% Owner
Transactions
- Sale
Common Stock
2021-03-10$195.90/sh−1$196→ 3,135,966 total - Sale
Common Stock
2021-03-10$196.12/sh−20$3,922→ 3,135,757 total - Sale
Common Stock
2021-03-10$198.00/sh−200$39,600→ 3,135,557 total - Exercise/Conversion
Common Stock
2021-03-10$0.00/sh+410$0→ 3,135,967 total - Exercise/Conversion
Common Stock
2021-03-09$0.00/sh+11,971$12→ 3,135,967 total - Exercise/Conversion
Warrant (right to purchase)
2020-03-09$5.60/sh−11,971$67,026→ 3,578,450 totalExercise: $0.00From: 2017-01-06→ Common Stock (11,971 underlying) - Exercise/Conversion
Warrant (right to purchase)
2020-03-10$5.60/sh−410$2,296→ 3,578,040 totalExercise: $0.00From: 2017-01-06→ Common Stock (410 underlying) - Sale
Common Stock
2021-03-09$197.30/sh−4,633$914,091→ 3,130,226 total - Sale
Common Stock
2021-03-09$197.81/sh−3,993$789,855→ 3,126,233 total - Sale
Common Stock
2021-03-10$195.52/sh−189$36,953→ 3,135,777 total - Sale
Common Stock
2021-03-09$195.82/sh−1,107$216,773→ 3,134,859 total - Sale
Common Stock
2021-03-09$199.08/sh−2,237$445,342→ 3,123,996 total - Sale
Common Stock
2021-03-09$191.00/sh−1$191→ 3,135,966 total
Braslyn Ltd.
10% Owner
Transactions
- Sale
Common Stock
2021-03-10$196.12/sh−20$3,922→ 3,135,757 total - Exercise/Conversion
Warrant (right to purchase)
2020-03-09$5.60/sh−11,971$67,026→ 3,578,450 totalExercise: $0.00From: 2017-01-06→ Common Stock (11,971 underlying) - Sale
Common Stock
2021-03-09$197.81/sh−3,993$789,855→ 3,126,233 total - Exercise/Conversion
Common Stock
2021-03-09$0.00/sh+11,971$12→ 3,135,967 total - Sale
Common Stock
2021-03-09$195.82/sh−1,107$216,773→ 3,134,859 total - Sale
Common Stock
2021-03-10$198.00/sh−200$39,600→ 3,135,557 total - Exercise/Conversion
Common Stock
2021-03-10$0.00/sh+410$0→ 3,135,967 total - Sale
Common Stock
2021-03-09$197.30/sh−4,633$914,091→ 3,130,226 total - Sale
Common Stock
2021-03-09$199.08/sh−2,237$445,342→ 3,123,996 total - Sale
Common Stock
2021-03-09$191.00/sh−1$191→ 3,135,966 total - Sale
Common Stock
2021-03-10$195.52/sh−189$36,953→ 3,135,777 total - Sale
Common Stock
2021-03-10$195.90/sh−1$196→ 3,135,966 total - Exercise/Conversion
Warrant (right to purchase)
2020-03-10$5.60/sh−410$2,296→ 3,578,040 totalExercise: $0.00From: 2017-01-06→ Common Stock (410 underlying)
Footnotes (7)
- [F1]Tese securities are owned directly by Braslyn Ltd ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the "Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
- [F2]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $195.24 to $196.20.
- [F3]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $196.55 to $197.53.
- [F4]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $197.56 to $198.23.
- [F5]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $198.62 to $199.46.
- [F6]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $195.11 to $196.09.
- [F7]The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001015747
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 9:30 PM ET
- Size
- 30.8 KB